Product Information

CHOLESTYRAMINE LIGHT PACKET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8034 per EA under NDC 68382052960. Its NADAC has been published 434 times since Apr 4, 2018.

FDA first approved this application on Apr 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CHOLESTYRAMINE LIGHT PACKET

CHOLESTYRAMINE
$0.8034per EA

Strength

4 g/5.5g

NDC

68382052960

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CHOLESTYRAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA202902

FDA Approved

4/25/2017

TE Code

AB

On Market Since

6/8/2017

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for CHOLESTYRAMINE LIGHT PACKET has been published 434 times since Apr 4, 2018, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8034 per EA
All-time high$1.8879 (Apr 11, 2018)
All-time low$0.7336 (Apr 17, 2024)
52-week high$0.9006
52-week low$0.7955
Median price$1.1860
Average price$1.1889
Largest weekly change+21.4% (Jun 19, 2024)
Weeks tracked434
Tracking sinceApr 4, 2018

Price History

1W

-0.2%

1M

-0.2%

3M

-1.4%

6M

-5.2%

1Y

-10.8%

3Y

-29.8%

5Y

-40.2%

All

-57.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 4%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CHOLESTYRAMINE LIGHT PACKET?

The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE LIGHT PACKET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8034 per EA (NDC 68382052960), effective Aug 19, 2026.

How has the price of CHOLESTYRAMINE LIGHT PACKET changed over time?

Over the history we have for it, the NADAC for CHOLESTYRAMINE LIGHT PACKET has declined 57.4%. It has been tracked across 434 weekly CMS publications since Apr 4, 2018.

What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE LIGHT PACKET?

Since Apr 4, 2018, the NADAC for CHOLESTYRAMINE LIGHT PACKET has ranged from a low of $0.7336 (Apr 17, 2024) to a high of $1.8879 (Apr 11, 2018), with a median of $1.1860 per EA.

Are there cheaper alternatives to CHOLESTYRAMINE LIGHT PACKET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE PACKET, is $0.7724 per EA — about 4% below CHOLESTYRAMINE LIGHT PACKET.

Who manufactures CHOLESTYRAMINE LIGHT PACKET?

CHOLESTYRAMINE LIGHT PACKET (NDC 68382052960) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.